Issue 39, 2022

Sustained-release nanocapsule based on a 3D COF for long-term enzyme prodrug therapy of cancer

Abstract

A well-designed three-dimensional (3D) covalent organic framework (COF) was constructed as a nanocapsule for the encapsulation of horseradish peroxidase (HRP), which could realize sustained release of HRP to prolong the duration of the therapeutic agents and promote long-term enzyme prodrug therapy.

Graphical abstract: Sustained-release nanocapsule based on a 3D COF for long-term enzyme prodrug therapy of cancer

Supplementary files

Article information

Article type
Communication
Submitted
19 Jan 2022
Accepted
12 Apr 2022
First published
22 Apr 2022

Chem. Commun., 2022,58, 5877-5880

Sustained-release nanocapsule based on a 3D COF for long-term enzyme prodrug therapy of cancer

X. Wan, J. Yin, Q. Yan, H. Hu, T. Zheng, Y. Chai, W. Pan, Y. Gao, N. Li and B. Tang, Chem. Commun., 2022, 58, 5877 DOI: 10.1039/D2CC00373B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements